Martin Butson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Martin Butson has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Dane Pope
Dept of Radiation Oncology, Chris O'Brien Lifehouse, Missenden Rd, Camperdown, NSW, Australia
2 shared publicationsEthan Butson
Institute of Medical Physics, School of Physics, The University of Sydney, Sydney, NSW, 2006, Australia
2 shared publicationsJohnny Morales
Department of Radiation Oncology, Chris O'Brien Lifehouse, 119 - 143 Missenden Road, Camperdown, NSW, 2050, Australia
2 shared publicationsMamoon Haque
Dept of Radiation Oncology, Chris O'Brien Lifehouse, Missenden Rd, Camperdown, NSW, Australia
2 shared publicationsMay Whitaker
Dept of Radiation Oncology, Chris O'Brien Lifehouse, Missenden Rd, Camperdown, NSW, Australia
2 shared publications- Robin Hill
Institute of Medical Physics, School of Physics, University of Sydney, Australia
2 shared publications
Latest Publications
- 9 September 2019
- Published by Springer Nature in Australasian Physics & Engineering Sciences in Medicine
- Vol. 42 (4) , 1177-1181
Skin and build up dose determination for a 2.5 MV medical linear accelerator imaging beam
The 2.5 MV Imaging beam produced by a Varian TrueBeam linear accelerator produces a dose build up effect at the beam entrance similar to other high energy photon beams. The surface dose values were found to range from 39% of maximum dose at a 5 cm × 5 cm field size up to 69% of maximum at a 40 cm × 40 cm field. The depth of maximum dose deposition was found to range from 5 mm at smaller field sizes to 4 mm at larger field sizes. Whilst large absorbed doses will not be delivered utilizing these beams, the data provided will allow the medical physics community to assess and estimate doses to patient’s skin and subcutaneous tissue from low energy MV imaging beams.
- 9 September 2019
- Published by Springer Nature in Australasian Physics & Engineering Sciences in Medicine
- Vol. 42 (4) , 1177-1181
Skin and build up dose determination for a 2.5 MV medical linear accelerator imaging beam
The 2.5 MV Imaging beam produced by a Varian TrueBeam linear accelerator produces a dose build up effect at the beam entrance similar to other high energy photon beams. The surface dose values were found to range from 39% of maximum dose at a 5 cm × 5 cm field size up to 69% of maximum at a 40 cm × 40 cm field. The depth of maximum dose deposition was found to range from 5 mm at smaller field sizes to 4 mm at larger field sizes. Whilst large absorbed doses will not be delivered utilizing these beams, the data provided will allow the medical physics community to assess and estimate doses to patient’s skin and subcutaneous tissue from low energy MV imaging beams.
- 13 February 2017
- Published by Springer Nature in Australasian Physics & Engineering Sciences in Medicine
- Vol. 40 (1) , 167-171
Practical time considerations for optically stimulated luminescent dosimetry (OSLD) in total body irradiation
Total body irradiation (TBI) treatments are used to treat the whole body in preparation for hematopoietic stem cell (or bone marrow) transplantation. Our standard clinical regimen is a 12 Gy in 6 fraction, bi-daily technique using 6 MV X-rays at an extended Source-to-Surface distance (SSD) of 300 cm. Utilizing these characteristics, the beam dose rate is reduced below 7 cGy/min as is standard for TBI treatment. Dose received by the patient is monitored using optically stimulated luminescent dosimetry (OSLD). This work presents some practical calibration corrections based on time-dependant factors for OSLD calibration related to TBI procedure. Results have shown that a negligible difference is seen in OSL sensitivity for 6 MV X-rays irradiated in standard SSD (100 cm) and high dose rate (600 cGy/min) conditions compared to extended SSD (300 cm) and low TBI dose rate (6 cGy/min) conditions. Results have also shown that whilst short term signal fading occurs in the OSL after irradiation at a high dose rate (37% reduction in signal in the first 15 min), thereafter, negligible differences are seen in the OSL signal between 600 and 7 cGy/min irradiations. Thus a direct comparison can be made between calibration OSLs and clinical TBI OSLs between 15 min and 2 h. Finally a table is presented to provide corrections between calibration OSL readout and clinical TBI dose readout for a period up to 7 days. Combining these three results allows users to pre-irradiate their calibration OSLs at standard dose rate and SSD, up to 1 week prior to clinical treatment, and still provide accurate in-vivo dosimetry. This can help with time saving and work efficiency in the clinic.
- 13 February 2017
- Published by Springer Nature in Australasian Physics & Engineering Sciences in Medicine
- Vol. 40 (1) , 167-171
Practical time considerations for optically stimulated luminescent dosimetry (OSLD) in total body irradiation
Total body irradiation (TBI) treatments are used to treat the whole body in preparation for hematopoietic stem cell (or bone marrow) transplantation. Our standard clinical regimen is a 12 Gy in 6 fraction, bi-daily technique using 6 MV X-rays at an extended Source-to-Surface distance (SSD) of 300 cm. Utilizing these characteristics, the beam dose rate is reduced below 7 cGy/min as is standard for TBI treatment. Dose received by the patient is monitored using optically stimulated luminescent dosimetry (OSLD). This work presents some practical calibration corrections based on time-dependant factors for OSLD calibration related to TBI procedure. Results have shown that a negligible difference is seen in OSL sensitivity for 6 MV X-rays irradiated in standard SSD (100 cm) and high dose rate (600 cGy/min) conditions compared to extended SSD (300 cm) and low TBI dose rate (6 cGy/min) conditions. Results have also shown that whilst short term signal fading occurs in the OSL after irradiation at a high dose rate (37% reduction in signal in the first 15 min), thereafter, negligible differences are seen in the OSL signal between 600 and 7 cGy/min irradiations. Thus a direct comparison can be made between calibration OSLs and clinical TBI OSLs between 15 min and 2 h. Finally a table is presented to provide corrections between calibration OSL readout and clinical TBI dose readout for a period up to 7 days. Combining these three results allows users to pre-irradiate their calibration OSLs at standard dose rate and SSD, up to 1 week prior to clinical treatment, and still provide accurate in-vivo dosimetry. This can help with time saving and work efficiency in the clinic.
- Open Access
- 1 January 2016
- Published by Medknow in Journal of Medical Physics
- Vol. 41 (2) , 149-52
Build-up material requirements in clinical dosimetry during total body irradiation treatments
Total body irradiation (TBI) treatments are mainly used in a preparative regimen for hematopoietic stem cell (or bone marrow) transplantation. Our standard clinical regimen is a 12 Gy/6 fraction bi-daily technique using 6MV X-rays at a large extended source to surface distance (SSD). This work investigates and quantifies the dose build-up characteristics and thus the requirements for bolus used for in vivo dosimetry for TBI applications. Percentage dose build-up characteristics of photon beams have been investigated at large extended SSDs using ionization chambers and Gafchromic film. Open field measurements at different field sizes and with differing scatter conditions such as the introduction of standard Perspex scattering plates at different distances to the measurement point were made in an effort to determine the required bolus/build-up material required for accurate determination of applied dose. Percentage surface dose values measured for open fields at 300 cm SSD were found to range from 20% up to 65.5% for fields 5 cm × 5 cm to 40 cm × 40 cm, respectively. With the introduction of 1 cm Perspex scattering plates used in TBI treatments, the surface dose values increased up to 83–90% (93–97% at 1 mm depth), depending on the position of the Perspex scattering plate compared to the measurement point. Our work showed that at least 5 mm water equivalent bolus/scatter material should be placed over the EBT3 film for accurate dose assessment for TBI treatments. Results also show that a small but measurable decrease in measured dose occurred with 5 mm water equivalent thick bolus material of areas '3 cm2. As such, we recommend that 3 cm × 3 cm × 5 mm bolus build-up is the smallest size that should be placed over EBT3 Gafchromic film when used for accurate in vivo dosimetry for TBI applications.
- 1 January 2016
- Published by Medknow in Journal of Medical Physics
- Vol. 41 (2) , 149-52
Open AccessBuild-up material requirements in clinical dosimetry during total body irradiation treatments
Total body irradiation (TBI) treatments are mainly used in a preparative regimen for hematopoietic stem cell (or bone marrow) transplantation. Our standard clinical regimen is a 12 Gy/6 fraction bi-daily technique using 6MV X-rays at a large extended source to surface distance (SSD). This work investigates and quantifies the dose build-up characteristics and thus the requirements for bolus used for in vivo dosimetry for TBI applications. Percentage dose build-up characteristics of photon beams have been investigated at large extended SSDs using ionization chambers and Gafchromic film. Open field measurements at different field sizes and with differing scatter conditions such as the introduction of standard Perspex scattering plates at different distances to the measurement point were made in an effort to determine the required bolus/build-up material required for accurate determination of applied dose. Percentage surface dose values measured for open fields at 300 cm SSD were found to range from 20% up to 65.5% for fields 5 cm × 5 cm to 40 cm × 40 cm, respectively. With the introduction of 1 cm Perspex scattering plates used in TBI treatments, the surface dose values increased up to 83–90% (93–97% at 1 mm depth), depending on the position of the Perspex scattering plate compared to the measurement point. Our work showed that at least 5 mm water equivalent bolus/scatter material should be placed over the EBT3 film for accurate dose assessment for TBI treatments. Results also show that a small but measurable decrease in measured dose occurred with 5 mm water equivalent thick bolus material of areas '3 cm2. As such, we recommend that 3 cm × 3 cm × 5 mm bolus build-up is the smallest size that should be placed over EBT3 Gafchromic film when used for accurate in vivo dosimetry for TBI applications.
- 4 June 1996
- Published by Wiley in Medical Physics
- Vol. 23 (6) , 953-955
Magnetic repulsion of linear accelerator contaminates
Neodymium Iron Boron (NdFeB) rare earth permanent magnets have unique properties that enable them to fit easily onto the accessory mount of a clinical linear accelerator to partially sweep away electron contamination produced by the treatment head and block trays and thus increase skin sparing. Using such magnets the central axis entrance surface dose has been reduced by 11% for a 20 x 30 cm field size from 32% to 21% of maximum dose by the magnetic device. A reduction of 14% from 32% to 18% was seen for a 20 x 20 cm field size with a 6 mm perspex block tray positioned above the magnet. The magnetic device is light weight and thus clinically usable.
- 4 June 1996
- Published by Wiley in Medical Physics
- Vol. 23 (6) , 953-955
Magnetic repulsion of linear accelerator contaminates
Neodymium Iron Boron (NdFeB) rare earth permanent magnets have unique properties that enable them to fit easily onto the accessory mount of a clinical linear accelerator to partially sweep away electron contamination produced by the treatment head and block trays and thus increase skin sparing. Using such magnets the central axis entrance surface dose has been reduced by 11% for a 20 x 30 cm field size from 32% to 21% of maximum dose by the magnetic device. A reduction of 14% from 32% to 18% was seen for a 20 x 20 cm field size with a 6 mm perspex block tray positioned above the magnet. The magnetic device is light weight and thus clinically usable.